These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11917785)
1. What's your assessment? Psoriasis with steroid atrophy. Bielan B Dermatol Nurs; 2001 Aug; 13(4):288, 318. PubMed ID: 11917785 [TBL] [Abstract][Full Text] [Related]
2. Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasis. Kosari P; Feldman SR Dermatol Online J; 2009 Mar; 15(3):15. PubMed ID: 19379659 [TBL] [Abstract][Full Text] [Related]
3. What's your assessment? Bielan B Dermatol Nurs; 2002 Apr; 14(2):99. PubMed ID: 12017088 [TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of halcinonide and fluocinonide creams in psoriasis and eszematous dermatoses. Sudilovsky A; Clewe TH J Clin Pharmacol; 1975; 15(11-12):779-84. PubMed ID: 1104668 [TBL] [Abstract][Full Text] [Related]
5. What's your assessment? Bielan B Dermatol Nurs; 2000 Oct; 12(5):351, 350. PubMed ID: 11912792 [TBL] [Abstract][Full Text] [Related]
6. Risks of unoccluded topical steroids in clinical trials. Akers WA Arch Dermatol; 1980 Jul; 116(7):786-8. PubMed ID: 6994659 [TBL] [Abstract][Full Text] [Related]
7. Extensive striae distensae as a result of topical corticosteroid therapy in psoriasis vulgaris. Rogalski C; Haustein UF; Glander HJ; Paasch U Acta Derm Venereol; 2003; 83(1):54-5. PubMed ID: 12636026 [No Abstract] [Full Text] [Related]
8. Transepidermal elimination following the use of a topical adrenal steroid. Katz R; Hood AF Arch Dermatol; 1985 Mar; 121(3):412-3. PubMed ID: 3977366 [No Abstract] [Full Text] [Related]
9. Keratoses following topical steroid for psoriasis. Tsuji T J Dermatol; 1993 Nov; 20(11):726-7. PubMed ID: 8300946 [No Abstract] [Full Text] [Related]
10. [Local treatment of psoriasis with glucocorticosteroids]. Marghescu S Hautarzt; 1985 Jan; 36(1):47-9. PubMed ID: 3972579 [TBL] [Abstract][Full Text] [Related]
11. What's your assessment? Acne rosacea. Bielan B Dermatol Nurs; 1998 Oct; 10(5):337-8. PubMed ID: 9873272 [TBL] [Abstract][Full Text] [Related]
14. Assessment of atrophogenicity of popularly prescribed topical corticosteroids. Dykes PJ; Marks R; Blakemore CB Br J Clin Pract; 1978 Dec; 32(12):345-8. PubMed ID: 737113 [No Abstract] [Full Text] [Related]
15. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle. Gans EH; Sadiq I; Stoudemayer T; Stoudemayer M; Kligman AM J Drugs Dermatol; 2008 Jan; 7(1):28-32. PubMed ID: 18246695 [TBL] [Abstract][Full Text] [Related]
16. Central serous retinopathy associated with topical oral corticosteroid use: a case report. O'Brien P; Young RC; Ghafoori SD; Harper CA; Wong RW J Med Case Rep; 2019 Jul; 13(1):201. PubMed ID: 31262360 [TBL] [Abstract][Full Text] [Related]